Hepatitis

Project ECHO: Extension for Community Healthcare Outcomes

Description

Connected urban medical center disease experts with rural general practitioners and community health representatives over a telehealth network to effectively treat patients with chronic, common and complex diseases who do not have direct access to specialty health care providers.

Grant Number
UC1 HS015135
Principal Investigator(s)

Peginterferon alfa-2a does not alter the pharmacokinetics of methadone in patients with chronic hepatitis C undergoing methadone maintenance therapy.

Principal Investigator

Treatment of chronic hepatitis C patients with persistently normal alanine aminotransferase levels with the combination of peginterferon alpha-2a (40 kDa) plus ribavirin: impact on health-related quality of life.

Principal Investigator

Virological response and safety outcomes in therapy-naive patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: a randomized, phase 2 study.

Principal Investigator

Project ECHO: Linking university specialists with rural and prison-based clinicians to improve care for people with chronic hepatitis C in New Mexico.

Principal Investigator